CNR Neuroscience Institute, Milano and NeuroMi Milan Center for Neuroscience, University of Milano-Bicocca, Milan, Italy.
CNR Neuroscience Institute, Milano and NeuroMi Milan Center for Neuroscience, University of Milano-Bicocca, Milan, Italy.
Curr Opin Pharmacol. 2021 Feb;56:93-101. doi: 10.1016/j.coph.2020.12.006. Epub 2021 Jan 8.
The N-methyl-d-aspartate (NMDA) receptor, among the ionotropic glutamate receptors, are fundamental to integrating and transducing complex signaling in neurons. Glutamate activation of these receptors mediates intracellular signals essential to neuronal and synaptic formation and synaptic plasticity and also contribute to excitotoxic processes in several neurological disorders. The NMDA receptor signaling is mediated by the permeability to Ca2+ and by the large network of signaling and scaffolding proteins associated mostly with the large C-terminal domain of GluN2 subunits. Important studies showed that GluN2 C-terminal interactions differ in accordance with the GluN2 subtype, and this influences the type of signaling that NMDA receptor activity controls. Thus, it is not surprising that mutations in genes that codify for NMDA receptor subunits have been associated with severe neuronal diseases. We will review recent advances and explore outstanding problems in this active area of research.
N-甲基-D-天冬氨酸(NMDA)受体属于离子型谷氨酸受体,对于整合和转导神经元中的复杂信号至关重要。这些受体的谷氨酸激活介导了对神经元和突触形成以及突触可塑性至关重要的细胞内信号,并且还导致几种神经疾病中的兴奋性毒性过程。NMDA 受体信号转导通过对 Ca2+的通透性以及与 GluN2 亚基的大 C 端结构域相关的大量信号和支架蛋白网络来介导。重要的研究表明,GluN2 C 端相互作用根据 GluN2 亚型而有所不同,这影响 NMDA 受体活性控制的信号类型。因此,编码 NMDA 受体亚基的基因突变与严重的神经元疾病有关,这并不奇怪。我们将综述这一活跃研究领域的最新进展并探讨悬而未决的问题。